![](/img/cover-not-exists.png)
A randomized phase II study of axitinib as maintenance therapy after first-line treatment for metastatic colorectal cancer
Grávalos, C., Carrato, A., Tobeña, M., Rodriguez-Garrote, M., Soler, G., Vieitez, J.M., Robles, L., Valladares-Ayerbes, M., Polo, E., Limón, M.L., Safont, M.J., Martínez de Castro, E., Alfonso, P. GarLanguage:
english
Journal:
Clinical Colorectal Cancer
DOI:
10.1016/j.clcc.2018.02.004
Date:
February, 2018
File:
PDF, 938 KB
english, 2018